ReRx Therapeutics
Biotechnology; Research
ReRx is developing novel, oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. Our therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents. ReRx is part of the Berkeley SkyDeck Cohort 17 (https://skydeck.berkeley.edu).
Open Positions at ReRx Therapeutics
0 positions available
No open positions at the moment
Check back later for new opportunities!